Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, announced today that the California Institute for Regenerative Medicine (CIRM) has awarded the company a ...
The California Institute for Regenerative Medicine (CIRM) celebrates a major milestone in the agency's 21-year history: the first approved therapy to come out of California taxpayer funding. The U.S.
South San Francisco, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- The California Institute for Regenerative Medicine (CIRM) has approved a new funding program to accelerate therapies for rare diseases, ...
Jonathan Thomas, PhD, JD has been appointed CIRM’s President and CEO · GlobeNewswire Inc. Jonathan Thomas, PhD, JD Jonathan Thomas, PhD, JD has been appointed CIRM’s President and CEO · GlobeNewswire ...
WOODBRIDGE, Conn.--(BUSINESS WIRE)--Cure Rare Disease (CRD) announced it has been awarded a $5.69 million grant from the California Institute for Regenerative Medicine (CIRM) to advance the ...
Institute also doled out its third Research Leadership award totaling $5.6 million. The California Institute for Regenerative Medicine (CIRM) reports that it has approved $27 million for two funds, ...
Charles A. "Chuck" Donovan is president of the Charlotte Lozier Institute, the research and education arm of the Susan B. Anthony List. Centrally planned job creation and scientific research pose many ...
SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered Treg and CAR-Treg cell ...
CIRM spokesperson Dale Carlson says that who is named as CIRM's next chief scientific officer will depend on who the agency selects as the next permanent president. Stay tuned to **__The Scientist__** ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results